Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 315 articles: HTML format

Single Articles

September 2025
1. ZHOU R, Jiajue R, Ni X, Pang Q, et al
   Glucose Metabolic Abnormalities and Their Interaction With Defective Phosphate Homeostasis in Tumor-induced Osteomalacia.
   J Clin Endocrinol Metab. 2025;110:2869-2878.
   PubMed     Abstract available
   
   
   
2. LAI KZH, Harris SB, Retnakaran R, Hanley AJG, et al
   Longitudinal Association of Statin Treatment With Insulin Sensitivity and Beta-Cell Function in the PROMISE Cohort.
   J Clin Endocrinol Metab. 2025;110:e3442-e3452.
   PubMed     Abstract available
   
   
   
3. MACLEOD SR, Tich JN, Marvald J, Zhang YV, et al
   The Influence of Social Vulnerability and Race on Diabetes Control.
   J Clin Endocrinol Metab. 2025 Sep 6:dgaf502. doi: 10.1210.
   PubMed     Abstract available
   
   
   
4. 
   Correction to: "Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline".
   J Clin Endocrinol Metab. 2025 Sep 3:dgaf494. doi: 10.1210.
   PubMed    
   
   
   August 2025
5. CHUBB SAP, Davis WA, Davis TME
   Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II.
   J Clin Endocrinol Metab. 2025 Aug 29:dgaf485. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. HANSEN JV, Mathiesen DS, Christensen MB, Jorgensen NR, et al
   The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetes.
   J Clin Endocrinol Metab. 2025 Aug 29:dgaf482. doi: 10.1210.
   PubMed     Abstract available
   
   
   
7. 
   Correction to: "The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study".
   J Clin Endocrinol Metab. 2025 Aug 26:dgaf471. doi: 10.1210.
   PubMed    
   
   
   
8. YOSHIJI S, Hasebe M, Tanaka D, Shimizu M, et al
   Genetic and Clinical Characteristics of Monogenic Diabetes in Japan: A Nationwide Study by the Japan Diabetes Society.
   J Clin Endocrinol Metab. 2025 Aug 25:dgaf478. doi: 10.1210.
   PubMed     Abstract available
   
   
   
9. BASU A
   Intensifying early diabetes education in youths with newly diagnosed type 1 diabetes for sustained glycemic outcomes.
   J Clin Endocrinol Metab. 2025 Aug 18:dgaf470. doi: 10.1210.
   PubMed    
   
   
   
10. LIN YT, Sayols-Baixeras S, Graells T, Dekkers KF, et al
    Identification of gut microbiome signatures and metabolites associated with albuminuria in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf453. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. YANG Y, Wang JH, Wang HA, Zhang TP, et al
    Blood plasma proteome-wide association study implicates new proteins in type 2 diabetes mellitus pathogenesis.
    J Clin Endocrinol Metab. 2025 Aug 12:dgaf462. doi: 10.1210.
    PubMed     Abstract available
    
    
    
12. SEVILLA-GONZALEZ M, Hanson PA, Islam J, Hsu S, et al
    Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf454. doi: 10.1210.
    PubMed     Abstract available
    
    
    
13. DEL PRATO S, Bonadonna RC
    Glucagon: The Arab Phoenix of the Complex Pathophysiology of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf421. doi: 10.1210.
    PubMed    
    
    
    
14. IGUDESMAN D, Nally LM, Grimshaw AA, Gunderson CG, et al
    Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials.
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf448. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. 
    Correction to: "A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy".
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf441. doi: 10.1210.
    PubMed    
    
    
    
16. MOHAN S, Christie HE, Laurenti MC, Egan AM, et al
    Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance.
    J Clin Endocrinol Metab. 2025;110:e2956-e2965.
    PubMed     Abstract available
    
    
    
17. GAMAGE IL, Barmanray RD, Kyi M, Colman PG, et al
    Early electronic specialist-led diabetes care improves post-discharge glycaemia: the STOIC-D Surgery follow-up cohort.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf440. doi: 10.1210.
    PubMed     Abstract available
    
    
    
18. HASEBE M, Su CY
    Letter to the Editor from Hasebe and Su: "Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study".
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf438. doi: 10.1210.
    PubMed    
    
    
    
19. MYERS R, Yildiz M, Nuri Ozbek M, Manzoor J, et al
    Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf430. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2025
20. YAN Y, Miao J, Sun Y
    Letter to the Editor from Yan et al.:A Low-Intensity Nutrition Intervention Targeting Triglycerides in Gestational Diabetes: A Feasibility RCT.
    J Clin Endocrinol Metab. 2025 Jul 23:dgaf413. doi: 10.1210.
    PubMed    
    
    
    
21. RODRIGUEZ GONZALEZ A, Harrison C, Hewitt B, Mejier JL, et al
    Feasibility, Acceptability, and Validity of Home Continuous Glucose Monitoring-Based Oral Glucose Tolerance Test in Youth.
    J Clin Endocrinol Metab. 2025;110:e2510-e2516.
    PubMed     Abstract available
    
    
    
22. KHORASHAD BS, Kaabi O, Gardner MD, Getahun D, et al
    Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2025;110:e2562-e2569.
    PubMed     Abstract available
    
    
    
23. KRAGELUND NIELSEN K, Dahl-Petersen IK, Jensen DM, Damm P, et al
    Effectiveness of a Family-based Health Promotion Intervention for Women With Prior GDM: The Face-It RCT.
    J Clin Endocrinol Metab. 2025;110:e2456-e2470.
    PubMed     Abstract available
    
    
    
24. TILLMAN JB, Beck RW, Polonsky WH, Calhoun P, et al
    Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis.
    J Clin Endocrinol Metab. 2025;110:2134-2146.
    PubMed     Abstract available
    
    
    
25. LAHOTI A, Haque MR, Bianco ME, Chaudhary A, et al
    Trends of Diabetes in Youth (TrenDY) during COVID-19 across the United States.
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf395. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. GURUNG RL, Zheng H, Tan JLI, Liu S, et al
    Response to Letter to the Editor from Hasebe and Su: "Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf406. doi: 10.1210.
    PubMed    
    
    
    
27. HASEBE M, Su CY
    Letter to the Editor from Hasebe and Su: "Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf405. doi: 10.1210.
    PubMed    
    
    
    
28. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf288. doi: 10.1210.
    PubMed     Abstract available
    
    
    
29. AL NOFAL A, Benkhadra K, Abbas A, Nduwimana MJ, et al
    A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf289. doi: 10.1210.
    PubMed     Abstract available
    
    
    
30. STECK AK, Parikh HM, Triolo TM, Ferrat L, et al
    Genetic Risk and Transition through Preclinical Stages of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf392. doi: 10.1210.
    PubMed     Abstract available
    
    
    
31. MICHELS AW, Brusko TM, Evans-Molina C, Homann D, et al
    Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf267. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2025
32. ASUZU P, Aliye N, Stentz F, Wan J, et al
    Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes.
    J Clin Endocrinol Metab. 2025 Jun 26:dgaf378. doi: 10.1210.
    PubMed     Abstract available
    
    
    
33. RELAN S, Alarcon G, Guffey D, Minard CG, et al
    Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population.
    J Clin Endocrinol Metab. 2025 Jun 24:dgaf360. doi: 10.1210.
    PubMed     Abstract available
    
    
    
34. FU Q, Dai H, Wang J, Liu L, et al
    Multidimensional Pancreatic Islet beta-cell Function (PIF) Assessment Improves Predictive Effect of Diabetes Risk Scores.
    J Clin Endocrinol Metab. 2025 Jun 23:dgaf372. doi: 10.1210.
    PubMed     Abstract available
    
    
    
35. SUN D, van Greevenbroek MMJ, Scheijen JLJM, Kelly J, et al
    Methylglyoxal Mediates the Association Between 2-Hour Plasma Glucose and HbA1c With Inflammation: The Maastricht Study.
    J Clin Endocrinol Metab. 2025;110:2047-2054.
    PubMed     Abstract available
    
    
    
36. BLAAK EE
    Precision approaches towards diabetes prevention: towards a clustering approach with more phenotypical granularity.
    J Clin Endocrinol Metab. 2025 Jun 13:dgaf341. doi: 10.1210.
    PubMed    
    
    
    
37. STAFFORD JM, Casanova R, Jaeger BC, Demesie Y, et al
    Prediabetes subgroups, type 2 diabetes risk, and differential effects of preventive interventions.
    J Clin Endocrinol Metab. 2025 Jun 11:dgaf350. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. ZHOU X, Zheng W, Kong W, Zhang J, et al
    Glucose Parameters, Inflammation Markers, and Gut Microbiota Changes of Gut Microbiome-Targeted Therapies in Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jun 9:dgaf340. doi: 10.1210.
    PubMed     Abstract available
    
    
    
39. MUNOZ-PARDEZA J, Gracia-Marco L, Lopez-Gil JF, Hormazabal-Aguayo I, et al
    The role of muscular fitness on bone mineral content and areal bone mineral density in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jun 5:dgaf328. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. COPETTI M, Menzaghi C, Trischitta V
    Predicting the effect of preventive treatment of type 2 diabetes. A further step towards precision medicine.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf327. doi: 10.1210.
    PubMed    
    
    
    
41. LAI SW
    Letter to the Editor from Lai: The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world study.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf325. doi: 10.1210.
    PubMed    
    
    
    
42. YU J, Kim B, Han K, Kim MK, et al
    Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study.
    J Clin Endocrinol Metab. 2025 Jun 3:dgaf249. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2025
43. GOWER BA, Yurchishin ML, Goss AM, Knight J, et al
    Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism.
    J Clin Endocrinol Metab. 2025 May 31:dgaf324. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. FRANK RC, Shim B, Lo T, Pandya D, et al
    Pancreatic Cancer Screening in New-Onset and Deteriorating Diabetes: Preliminary Results from the PANDOME Study.
    J Clin Endocrinol Metab. 2025 May 29:dgaf319. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. XU B, Yang X, Ma Y, Jiang Y, et al
    Association Between Free Triiodothyronine and Diabetic Peripheral Neuropathy in Euthyroid Patients With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 May 27:dgaf304. doi: 10.1210.
    PubMed     Abstract available
    
    
    
46. JACK GA, Avenatti E, Kashyap SR, Sadhu AR, et al
    Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 May 27:dgaf301. doi: 10.1210.
    PubMed     Abstract available
    
    
    
47. YANG X, Zhao X, Jiang Y
    Letter to the Editor From Yang et al: "Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study".
    J Clin Endocrinol Metab. 2025 May 24:dgaf307. doi: 10.1210.
    PubMed    
    
    
    
48. OYEKA CP, He JH, Ma J, Michos ED, et al
    Role of Sex Hormones in Mediating Adiposity Changes from Weight Loss in People with Type 2 Diabetes: Look AHEAD Sex Hormone Study.
    J Clin Endocrinol Metab. 2025 May 20:dgaf287. doi: 10.1210.
    PubMed     Abstract available
    
    
    
49. VAIZOGLU RD, Erdem B, Gul M, Acar C, et al
    Investigation of Fibrillar Aggregates Formed by Pathogenic Pre-pro-vasopressin Mutants that Cause ADNDI.
    J Clin Endocrinol Metab. 2025;110:1577-1586.
    PubMed     Abstract available
    
    
    
50. BIAGETTI B, Cordero Asanza E, Perez-Lopez C, Araujo-Castro M, et al
    Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study.
    J Clin Endocrinol Metab. 2025;110:e1811-e1820.
    PubMed     Abstract available
    
    
    
51. LU X, Zhu X, Li G, Wu L, et al
    Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity.
    J Clin Endocrinol Metab. 2025;110:e1845-e1855.
    PubMed     Abstract available
    
    
    
52. TATSUKAWA Y, Sposto R, Yamada M, Ohishi W, et al
    Relationship Between Radiation Dose and Markers of Insulin Resistance and Inflammation in Atomic Bomb Survivors.
    J Clin Endocrinol Metab. 2025;110:e1943-e1950.
    PubMed     Abstract available
    
    
    
53. POHLMAN N, Patel PN, Essien UR, Tang JJ, et al
    Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era.
    J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210.
    PubMed     Abstract available
    
    
    
54. LIU K, Clarke GS, Grieger JA
    A low-intensity nutrition intervention targeting triglycerides in gestational diabetes: a feasibility RCT.
    J Clin Endocrinol Metab. 2025 May 16:dgaf291. doi: 10.1210.
    PubMed     Abstract available
    
    
    
55. LIU JJ, Liu S, Gurung RL, Lee J, et al
    Urine choline oxidation metabolites predict chronic kidney disease progression in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2025 May 13:dgaf281. doi: 10.1210.
    PubMed     Abstract available
    
    
    
56. DE MEULEMEESTER J, Valgaerts L, Massa G, Gies I, et al
    Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 May 7:dgaf265. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2025
57. WANG L, Lin H, Zhao Z, Chen L, et al
    Regional Brain Structure Alterations in Diabetes but Not Prediabetes: the Shanghai Changfeng Study.
    J Clin Endocrinol Metab. 2025 Apr 30:dgaf248. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. GOEDECKE JH, Kufe CN, Masemola M, Lichaba M, et al
    SHBG, testosterone and type 2 diabetes risk in middle-aged African women: exploring the impact of HIV and menopause.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf256. doi: 10.1210.
    PubMed     Abstract available
    
    
    
59. JAEGER B, Casanova R, Demesie Y, Stafford J, et al
    Development and validation of a diabetes risk prediction model with individualized preventive intervention effects.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf250. doi: 10.1210.
    PubMed     Abstract available
    
    
    
60. BRANDT IAG, Vestergaard P, Harslof T, Juhl CB, et al
    Association between Muscle status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf245. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. KANG F, Zhang Z, Fu H, Sun J, et al
    beta-Cell Dedifferentiation in HOMA-betalow and HOMA-betahigh Subjects.
    J Clin Endocrinol Metab. 2025;110:e1430-e1438.
    PubMed     Abstract available
    
    
    
62. HSU JC, Huang KC, Lin TT, Lee JK, et al
    Epicardial Adipose Tissue Is Associated With Geometry Alteration and Diastolic Dysfunction in Prediabetic Cardiomyopathy.
    J Clin Endocrinol Metab. 2025;110:1478-1487.
    PubMed     Abstract available
    
    
    
63. GLAROS SB, Dixon SD, Malandrino N, Davis FS, et al
    Navigating transition to adult care in youth-onset type 2 diabetes: Facilitators, Attitudes, Barriers, and Behaviors.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf239. doi: 10.1210.
    PubMed     Abstract available
    
    
    
64. SU W, Yang Y, Cheng J, Dong N, et al
    The microbial regulation spectrum of metformin in patients with type 2 diabetes: An individual-based meta-analysis of 1431 participants.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf238. doi: 10.1210.
    PubMed     Abstract available
    
    
    
65. CHEN C, Yu L, Lan MS
    Modulation of Functional Activity of INS-VNTR Class I Haplotype Derived from Type 1 Diabetic Patients.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf243. doi: 10.1210.
    PubMed     Abstract available
    
    
    
66. ZHANG J, Tam WWS, Lu J, Chen J, et al
    Response to Letter to the Editor from Bai and Zhang: "Cognitive Risk Stratification Score in Middle-aged and Older Adults with Type 2 Diabetes: A Cross-Sectional Study.".
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf241. doi: 10.1210.
    PubMed    
    
    
    
67. BAI Y, Zhang F
    Letter to the Editor from Bai and Zhang: "Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study.".
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf240. doi: 10.1210.
    PubMed    
    
    
    
68. DEUTSCH AJ, Udler MS
    Phenotypic and genetic diversity in diabetes across populations.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf234. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. 
    Correction to: "Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial".
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf205. doi: 10.1210.
    PubMed    
    
    
    
70. KVIST AV, Frost M, Burden AM, Vestergaard P, et al
    Direct healthcare cost of fractures in patients with type 1 diabetes: a population-based cohort study in Denmark.
    J Clin Endocrinol Metab. 2025 Apr 10:dgaf199. doi: 10.1210.
    PubMed     Abstract available
    
    
    
71. FALCETTA P, Zilich R, Baccetti F, Baronti W, et al
    Treatment intensification strategies and metabolic outcomes in individuals with type 2 diabetes on GLP-1 RA therapy.
    J Clin Endocrinol Metab. 2025 Apr 9:dgaf229. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. LU W, Shen D, Qiu S
    Association between visit-to-visit glucose variability and brain morphology and cognitive function in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Apr 8:dgaf228. doi: 10.1210.
    PubMed     Abstract available
    
    
    
73. TELES BSBS, Ramalho SHR, Bittencourt MS, Bensenor IM, et al
    Plasma levels of small HDL particles are associated with coronary atherosclerosis progression in adults with diabetes.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf215. doi: 10.1210.
    PubMed     Abstract available
    
    
    
74. DIXON SB
    Diabetes risk in young survivors of childhood cancer: a need for prevention and survivor-specific treatment strategies.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf202. doi: 10.1210.
    PubMed    
    
    
    
75. LEICHTER SB, Felton JL, Rasmussen CG, Rizzuto P, et al
    Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf194. doi: 10.1210.
    PubMed     Abstract available
    
    
    
76. HUANG B, Kao YW, Yen KC, Chen SW, et al
    Effect of Initial eGFR and Albuminuria Changes on Clinical Outcomes in People With Diabetes Receiving SGLT2 Inhibitors.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf133. doi: 10.1210.
    PubMed     Abstract available
    
    
    
77. MONTASER E, Abad SE, Shah VN
    Changes in A1C versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf211. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2025
78. THURBER EG, Lan Z, Turchin A
    Telemedicine Visit Use and Glycemic Control in Patients with Diabetes.
    J Clin Endocrinol Metab. 2025 Mar 26:dgaf177. doi: 10.1210.
    PubMed     Abstract available
    
    
    
79. STEINMETZ T, Goldman S, Kagan KBT, Bielopolski D, et al
    The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world study.
    J Clin Endocrinol Metab. 2025 Mar 22:dgaf184. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. GALINDO RJ, Moazzami B, Gerges A, Flores I, et al
    Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 22:dgaf187. doi: 10.1210.
    PubMed     Abstract available
    
    
    
81. ONENGUT-GUMUSCU S, Concannon P, Akolkar B, Erlich HA, et al
    The Type 1 Diabetes Genetics Consortium (T1DGC).
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
    PubMed     Abstract available
    
    
    
82. MITA T, Osonoi Y, Someya Y, Osonoi T, et al
    Relationship of carbohydrate intake proportion to cardiovascular events in Japanese people with type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf179. doi: 10.1210.
    PubMed     Abstract available
    
    
    
83. CHEN Z, Wu X, Yang Q, Zhao H, et al
    The Effect of SGLT2 Inhibition on Brain-related Phenotypes and Aging: A Drug Target Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2025;110:1096-1104.
    PubMed     Abstract available
    
    
    
84. PETERS AL, Buzzetti R, Lee CJ, Pavo I, et al
    Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
    J Clin Endocrinol Metab. 2025;110:e962-e969.
    PubMed     Abstract available
    
    
    
85. STEFANOVSKI D, Smiley DD, Punjabi NM, Umpierrez GE, et al
    Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test.
    J Clin Endocrinol Metab. 2025;110:e1108-e1115.
    PubMed     Abstract available
    
    
    
86. LIU M, Gao M, Wu J, Zhu Z, et al
    Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants.
    J Clin Endocrinol Metab. 2025;110:e1211-e1219.
    PubMed     Abstract available
    
    
    
87. 
    Correction to: "Approach to Lipid Management in the Patient With Diabetes".
    J Clin Endocrinol Metab. 2025 Mar 14:dgaf161. doi: 10.1210.
    PubMed    
    
    
    
88. HUANG H, Cai J, Hu H, Cai L, et al
    Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Mar 13:dgaf172. doi: 10.1210.
    PubMed     Abstract available
    
    
    
89. KONDO T, Senokuchi T, Yano M, Takeda H, et al
    Benefits and Accuracy of Real-Time CGM in Children and Adolescents with Type 1 Diabetes Attending Summer Camp: 2nd year.
    J Clin Endocrinol Metab. 2025 Mar 12:dgaf160. doi: 10.1210.
    PubMed     Abstract available
    
    
    
90. STROEBEL BM, Gadgil M, Lewis K, Longoria K, et al
    Body Composition Differentiates Prediabetes Phenotype Clusters in the Diabetes Prevention Program Study.
    J Clin Endocrinol Metab. 2025 Mar 11:dgaf163. doi: 10.1210.
    PubMed     Abstract available
    
    
    
91. MULLER NZ, Muresan IM, Kunzi A, Borojevic ZZ, et al
    Antibodies are predictive for diagnosis of celiac disease in pediatric type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf146. doi: 10.1210.
    PubMed     Abstract available
    
    
    
92. NIERVES LA, Lin TT, Moradian A, Shen Q, et al
    Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical Research.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
    PubMed     Abstract available
    
    
    
93. 
    Correction to: "Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism".
    J Clin Endocrinol Metab. 2025 Mar 7:dgaf119. doi: 10.1210.
    PubMed    
    
    
    
94. MUIR CA, Wittert GA, Handelsman DJ
    Approach to the patient: Low testosterone concentrations in men with obesity.
    J Clin Endocrinol Metab. 2025 Mar 7:dgaf137. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2025
95. HENSKE J, Turner LV, Riddell MC
    Approach to the Patient: Type 1 Diabetes Management with Exercise - Prepare, Perform, Stabilize, and Study.
    J Clin Endocrinol Metab. 2025 Feb 28:dgaf136. doi: 10.1210.
    PubMed     Abstract available
    
    
    
96. HATIPOGLU B, Pronovost PJ
    Role of Diabetes Self-management Education for Our Health Systems and Economy.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
97. FETZNER J, Rafi E
    Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
98. BLANCHETTE JE, Nally LM, Wentzell K, Hughes AS, et al
    Insights on Improving Health Insurance Literacy in Diabetes.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
99. RAFI E, Tranchito L, Hatipoglu B
    Navigating Insulin Options for Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
100. BASKIN RG, Karp KA
     Navigating the Spectrum of 4 Evidence-Based Nutrition Options for Type 2 Diabetes Management.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
101. TENREIRO K, Hatipoglu B
     Mind Matters: Mental Health and Diabetes Management.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
102. BLANCHETTE JE, Paquin F, Dobbs BN, Kiely RL, et al
     Incorporating Complementary Therapies Into Diabetes Care.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
103. HATIPOGLU B
     Editorial: A Guidebook for Providers on Comprehensive Diabetes Care.
     J Clin Endocrinol Metab. 2025;110.
     PubMed    
     
     
     
104. LUNDGRIN EL, Hatipoglu B
     Trending Modalities in Type 2 Diabetes Prevention.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
105. TSUSHIMA Y, Galloway N
     Glycemic Targets and Prevention of Complications.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
106. LUNDGRIN EL, Kelly CA, Bellini N, Lewis C, et al
     Diabetes Technology Trends: A Review of the Latest Innovations.
     J Clin Endocrinol Metab. 2025;110.
     PubMed     Abstract available
     
     
     
107. HSIAO YY, Chen YY, Kuo MJ, Chien YS, et al
     SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort Study.
     J Clin Endocrinol Metab. 2025 Feb 25:dgae861. doi: 10.1210.
     PubMed     Abstract available
     
     
     
108. GALDERISI A, Bonet J, Ismail HM, Moran A, et al
     Metabolic phenotype of Stage 1 and Stage 2 type 1 diabetes using modelling of beta cell function.
     J Clin Endocrinol Metab. 2025 Feb 24:dgaf086. doi: 10.1210.
     PubMed     Abstract available
     
     
     
109. NAKAMURA T, Tsujimoto T, Yasuda K, Kajio H, et al
     Consistently low serum levels of MG-H1 is associated with a lower risk of diabetic kidney disease.
     J Clin Endocrinol Metab. 2025 Feb 22:dgaf098. doi: 10.1210.
     PubMed     Abstract available
     
     
     
110. BUROKAS A, Mela V
     Cognitive risk stratification in type 2 diabetes: a step toward early detection.
     J Clin Endocrinol Metab. 2025 Feb 19:dgaf105. doi: 10.1210.
     PubMed    
     
     
     
111. WEN Z, Liu X, Liu H
     Letter to the Editor from [Wen et al.]: "[Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes].".
     J Clin Endocrinol Metab. 2025 Feb 18:dgaf091. doi: 10.1210.
     PubMed    
     
     
     
112. NOMOTO H, Furusawa S, Yokoyama H, Suzuki Y, et al
     Improvement of beta-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis.
     J Clin Endocrinol Metab. 2025;110:e583-e591.
     PubMed     Abstract available
     
     
     
113. LIU S, Wan H, Nie S, Cao H, et al
     Dipeptidyl Peptidase 4 Inhibitors vs Metformin for New-onset Dementia: A Propensity Score-matched Cohort Study.
     J Clin Endocrinol Metab. 2025;110:e650-e659.
     PubMed     Abstract available
     
     
     
114. GURUNG RL, Zheng H, Tan JLI, Liu S, et al
     Plasma proteins predict kidney function trajectories in type 2 diabetes.
     J Clin Endocrinol Metab. 2025 Feb 14:dgaf095. doi: 10.1210.
     PubMed     Abstract available
     
     
     
115. ANDERSSON M, Agren A, Henriksson P, Wallen H, et al
     Influence of bariatric surgery on endothelial and glycocalyx biomarkers in obesity and type 2 diabetes.
     J Clin Endocrinol Metab. 2025 Feb 13:dgaf092. doi: 10.1210.
     PubMed     Abstract available
     
     
     
116. WITTERT GA, Robledo KP, Handelsman DJ, Inder WJ, et al
     Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial.
     J Clin Endocrinol Metab. 2025 Feb 10:dgaf060. doi: 10.1210.
     PubMed     Abstract available
     
     
     
117. OLSEN MT, Liarakos AL, Wilmot EG, Dhatariya K, et al
     Implementation strategies for inpatient continuous glucose monitoring-based diabetes management: a systematic review.
     J Clin Endocrinol Metab. 2025 Feb 7:dgaf074. doi: 10.1210.
     PubMed     Abstract available
     
     
     
118. BOLIER M, de Winter DTC, Fiocco M, van den Berg SAA, et al
     Prevalence and determinants of diabetes mellitus in 2,338 long-term Dutch childhood cancer survivors (DCCS-LATER2 Study).
     J Clin Endocrinol Metab. 2025 Feb 7:dgaf078. doi: 10.1210.
     PubMed     Abstract available
     
     
     
119. UNNI US, Bril F, Mugler JP 3rd, Carter RE, et al
     Role of Hepatic Glycogen on Nocturnal Gluconeogenesis in Type 2 Diabetes Mellitus.
     J Clin Endocrinol Metab. 2025 Feb 4:dgaf044. doi: 10.1210.
     PubMed     Abstract available
     
     
     
120. NOONAN SB, Brennecke SP, Jones GD
     Predicting Preeclampsia in Gestational Diabetes Mellitus using the sFlt-1/PlGF Ratio.
     J Clin Endocrinol Metab. 2025 Feb 4:dgaf069. doi: 10.1210.
     PubMed     Abstract available
     
     
     
121. CAMOIN M, Mohammedi K, Saulnier PJ, Hadjadj S, et al
     Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.
     J Clin Endocrinol Metab. 2025 Feb 4:dgae852. doi: 10.1210.
     PubMed     Abstract available
     
     
     
122. ZHANG J, Tam WWS, Lu J, Chen J, et al
     Cognitive Risk Stratification Score in Middle-aged and Older Adults with Type 2 Diabetes: a Cross-Sectional Study.
     J Clin Endocrinol Metab. 2025 Feb 4:dgaf063. doi: 10.1210.
     PubMed     Abstract available
     
     
     
123. HUANG X, Xu Q, Chen L, Liu L, et al
     Potential mechanism associated with post-heart transplantation diabetes mellitus in Chinese patients.
     J Clin Endocrinol Metab. 2025 Feb 1:dgaf071. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2025
124. DIEDISHEIM M, Mallone R, Pugliese A, Dubois-Laforgue D, et al
     Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes.
     J Clin Endocrinol Metab. 2025 Jan 28:dgaf039. doi: 10.1210.
     PubMed     Abstract available
     
     
     
125. NISHIKAGE S, Hirota Y, Takayoshi T, Yoshimura K, et al
     Utility of the C-peptide/insulin molar ratio for distinguishing type A insulin resistance syndrome from type 2 diabetes.
     J Clin Endocrinol Metab. 2025 Jan 28:dgaf043. doi: 10.1210.
     PubMed     Abstract available
     
     
     
126. SASO-JIMENEZ L, Urrutia I, Calvo B, Bilbao JR, et al
     Searching for monogenic autoimmune etiology in patients with type 1 diabetes onset under 30 months of age.
     J Clin Endocrinol Metab. 2025 Jan 28:dgaf049. doi: 10.1210.
     PubMed     Abstract available
     
     
     
127. FERRARI S, Betah D, Feldman RG, Langdahl BL, et al
     Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.
     J Clin Endocrinol Metab. 2025 Jan 24:dgae862. doi: 10.1210.
     PubMed     Abstract available
     
     
     
128. FISHER M, Smith G, Potter BK, Arbuckle TE, et al
     The Association between Pregnancy Complications and Long-Term Maternal Cardiometabolic Health in the MIREC Cohort Study.
     J Clin Endocrinol Metab. 2025 Jan 23:dgaf041. doi: 10.1210.
     PubMed     Abstract available
     
     
     
129. LIANG Y, Lim CGY, Ritchie SC, Bertin N, et al
     Circulating proteomic profiles are associated with type 2 diabetes in Asian populations - a longitudinal study.
     J Clin Endocrinol Metab. 2025 Jan 22:dgaf045. doi: 10.1210.
     PubMed     Abstract available
     
     
     
130. LEWIS C, Rafi E, Dobbs B, Barton T, et al
     Tailoring Exercise Prescription for Effective Diabetes Glucose Management.
     J Clin Endocrinol Metab. 2025 Jan 21:dgae908. doi: 10.1210.
     PubMed     Abstract available
     
     
     
131. PAPADIMITRIOU DT
     Letter to the Editor From Papadimitriou: "Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes".
     J Clin Endocrinol Metab. 2025 Jan 21:dgaf029. doi: 10.1210.
     PubMed    
     
     
     
132. AHMED F, Hetty S, Laterveer R, Surucu EB, et al
     Altered expression of aromatase and estrogen receptors in adipose tissue from men with obesity or type 2 diabetes.
     J Clin Endocrinol Metab. 2025 Jan 21:dgaf038. doi: 10.1210.
     PubMed     Abstract available
     
     
     
133. JENSEN NJ, Porse AJ, Wodschow HZ, Speyer H, et al
     Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2025;110:e525-e537.
     PubMed     Abstract available
     
     
     
134. NEWELL-PRICE J, Drummond JB, Gurnell M, Levy M, et al
     Approach to the Patient With Suspected Hypotonic Polyuria.
     J Clin Endocrinol Metab. 2025;110:e506-e514.
     PubMed     Abstract available
     
     
     
135. BATTILLO DJ, Remchak ME, Shah AM, Malin SK, et al
     Impact of Insulin-Induced Relative Hypoglycemia on Vascular Insulin Sensitivity and Central Hemodynamics in Prediabetes.
     J Clin Endocrinol Metab. 2025;110:e423-e431.
     PubMed     Abstract available
     
     
     
136. MISKELLY MG, Berggren J, Svensson M, Koffert J, et al
     The Effects of Calorie Restriction and Bariatric Surgery on Circulating Proneurotensin Levels.
     J Clin Endocrinol Metab. 2025;110:e497-e505.
     PubMed     Abstract available
     
     
     
137. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
     Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls.
     J Clin Endocrinol Metab. 2025 Jan 20:dgaf030. doi: 10.1210.
     PubMed     Abstract available
     
     
     
138. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
     Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
     J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
     PubMed     Abstract available
     
     
     
139. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
     Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
     J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
     PubMed     Abstract available
     
     
     
140. AN J, Zhang S, Cheng X, Jia C, et al
     The Association between Serum Polychlorinated Biphenyls and Incident Cardiovascular Disease among Type 2 Diabetes.
     J Clin Endocrinol Metab. 2025 Jan 15:dgaf014. doi: 10.1210.
     PubMed     Abstract available
     
     
     
141. GERA S, Rearson A, Baker G, Douvas JL, et al
     Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
     J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
     PubMed     Abstract available
     
     
     
142. WANG S, Zhang Y, Balati A, Li B, et al
     Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
     J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
     PubMed     Abstract available
     
     
     
143. KIM S, Subramanian S
     Approach to Lipid Management in the Patient with Diabetes.
     J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
     PubMed     Abstract available
     
     
     
144. HAAS AV, Koefoed AW, Celli J, Bonyhay I, et al
     Effect of Hypoglycemia on QT Interval in Individuals with and without Type 2 Diabetes: A Randomized Crossover Trial.
     J Clin Endocrinol Metab. 2025 Jan 9:dgae919. doi: 10.1210.
     PubMed     Abstract available
     
     
     
145. DICKENS LT, Gonzalez MG
     Approach to the Patient using Diabetes Technology in Pregnancy.
     J Clin Endocrinol Metab. 2025 Jan 7:dgae914. doi: 10.1210.
     PubMed     Abstract available
     
     
     
146. AMENDOLARA R, D'Onofrio L, Sessa RL, Di Giulio S, et al
     IFN-alpha neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
     J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210.
     PubMed     Abstract available
     
     
     December 2024
147. YANG X, Peng J, Sun F, Wu P, et al
     Renal function and risk of gestational diabetes mellitus: the potential mediating role of carnitine metabolites.
     J Clin Endocrinol Metab. 2024 Dec 18:dgae881. doi: 10.1210.
     PubMed     Abstract available
     
     
     
148. JALLEH RJ, Plummer MP, Marathe CS, Umapathysivam MM, et al
     Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
     J Clin Endocrinol Metab. 2024;110:1-15.
     PubMed     Abstract available
     
     
     
149. SCHAUER PR, Rothberg AE
     Point-Counterpoint Debate: Surgery vs. Medical Treatment for the Management of Obesity.
     J Clin Endocrinol Metab. 2024 Dec 18:dgae888. doi: 10.1210.
     PubMed     Abstract available
     
     
     
150. BHATTACHARYA S, Nagendra L, Dutta D, Kamrul-Hasan ABM, et al
     Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2024 Dec 17:dgae878. doi: 10.1210.
     PubMed     Abstract available
     
     
     
151. BASKOY G, Peterson R, Kempenich J, Triplitt C, et al
     Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Type 2 Diabetes Patients: A Pilot Study.
     J Clin Endocrinol Metab. 2024 Dec 17:dgae872. doi: 10.1210.
     PubMed     Abstract available
     
     
     
152. GENOSAR R, Coman MM, Herold KC
     Reversing diabetes with your own cells: Closer to the dream.
     J Clin Endocrinol Metab. 2024 Dec 13:dgae851. doi: 10.1210.
     PubMed    
     
     
     
153. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
     Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
     PubMed     Abstract available
     
     
     
154. YOUSIF MF, Dolak KD, Adhikari S, White PC, et al
     A nested case-control study of adverse outcomes in children with diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae848. doi: 10.1210.
     PubMed     Abstract available
     
     
     
155. YUEN L, Wong V, Immanuel J, Hague WM, et al
     Ethnic Differences in Characteristics of Women Diagnosed with Early Gestational Diabetes: Findings from the TOBOGM Study.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae838. doi: 10.1210.
     PubMed     Abstract available
     
     
     
156. FRANKS PW, Rich SS, Linder B, Zaghloul NA, et al
     A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae844. doi: 10.1210.
     PubMed     Abstract available
     
     
     
157. LIN YK, Ye W, Hepworth E, Rickels MR, et al
     Impaired Awareness and Symptomatology of Hypoglycemia in Adults with Type 1 Diabetes using Continuous Glucose Monitoring.
     J Clin Endocrinol Metab. 2024 Dec 5:dgae846. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2024
158. JIANG X, Zhu F, Graca G, Du X, et al
     Serum metabolomic profiling of incident type 2 diabetes mellitus in the Multi-Ethnic Study of Atherosclerosis and Rotterdam Study.
     J Clin Endocrinol Metab. 2024 Nov 20:dgae812. doi: 10.1210.
     PubMed     Abstract available
     
     
     
159. SMEW AI, Lundholm C, Gong T, Lichtenstein P, et al
     Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Nov 18:dgae809. doi: 10.1210.
     PubMed     Abstract available
     
     
     
160. MATHER KJ, Mari A, Heise T, DeVries JH, et al
     Effects of Tirzepatide vs Semaglutide on beta-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.
     J Clin Endocrinol Metab. 2024;109:3046-3054.
     PubMed     Abstract available
     
     
     
161. SIMONSON DC, Testa MA, Ekholm E, Su M, et al
     Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
     J Clin Endocrinol Metab. 2024;109:e2261-e2272.
     PubMed     Abstract available
     
     
     
162. YARDLEY JE, Li Z, Zaharieva DP, Riddell MC, et al
     Sex Differences in Glycemia and Self-Management Strategies for Exercise in an Active Adults Cohort with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Nov 14:dgae792. doi: 10.1210.
     PubMed     Abstract available
     
     
     
163. CHANG LY, Liao HW, Chen JY, Wu VC, et al
     Enhanced Outcomes in Type 2 Diabetes Patients with Acute Kidney Disease Through Thiazolidinedione.
     J Clin Endocrinol Metab. 2024 Nov 13:dgae796. doi: 10.1210.
     PubMed     Abstract available
     
     
     
164. PHAM UN, Pryke A, Baskerville T, Griffin A, et al
     Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Nov 11:dgae787. doi: 10.1210.
     PubMed     Abstract available
     
     
     
165. WANG B, Dhaliwal R, Ewing SK, Schwartz AV, et al
     F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Nov 8:dgae788. doi: 10.1210.
     PubMed     Abstract available
     
     
     
166. FENG Y, Shang B, Yang Y, Zhang D, et al
     Impact of DPP-4 inhibitors on interleukin levels in type 2 diabetes mellitus.
     J Clin Endocrinol Metab. 2024 Nov 8:dgae783. doi: 10.1210.
     PubMed     Abstract available
     
     
     
167. ZHOU Q, Samadli S, Zhang H, Zheng X, et al
     Molecular and clinical profiles of pediatric monogenic diabetes subtypes: comprehensive genetic analysis of 138 patients.
     J Clin Endocrinol Metab. 2024 Nov 6:dgae779. doi: 10.1210.
     PubMed     Abstract available
     
     
     
168. ALARCON G, Nguyen A, Jones A, Shields B, et al
     The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth.
     J Clin Endocrinol Metab. 2024 Nov 4:dgae770. doi: 10.1210.
     PubMed     Abstract available
     
     
     
169. KAJITANI N, Umakoshi H, Kajitani Y, Kaneko H, et al
     Relationship between extracellular water to total body water ratio and severe diabetic retinopathy in type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Nov 1:dgae768. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2024
170. BOUGHANEM H, de Larriva APA, Camargo A, Torres-Pena JD, et al
     Decreased neutrophils are associated with reduced risk of Type 2 Diabetes Incidence: Results from the CORDIOPREV study.
     J Clin Endocrinol Metab. 2024 Oct 29:dgae736. doi: 10.1210.
     PubMed     Abstract available
     
     
     
171. GONG Y, Wang Q, Chen S, Liu Y, et al
     Heterogeneity of gestational diabetes and risk for adverse pregnancy outcome: a cohort study.
     J Clin Endocrinol Metab. 2024 Oct 24:dgae754. doi: 10.1210.
     PubMed     Abstract available
     
     
     
172. SHEHADEH N, Galassetti P, Iqbal N, Karlsson C, et al
     Safety, Growth and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).
     J Clin Endocrinol Metab. 2024 Oct 24:dgae723. doi: 10.1210.
     PubMed     Abstract available
     
     
     
173. GOWER BA, Goss AM, Yurchishin ML, Deemer SE, et al
     Effects of a Carbohydrate-Restricted Diet on beta-Cell Response in Adults With Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Oct 22:dgae670. doi: 10.1210.
     PubMed     Abstract available
     
     
     
174. JOHNSON RJ, Bergford S, Gal RL, Calhoun P, et al
     The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Oct 18:dgae725. doi: 10.1210.
     PubMed     Abstract available
     
     
     
175. BHAT SZ, Wu J, Perin J, Wang K, et al
     Effectiveness of Dexamethasone for COVID-19 in Hospitalized Patients with Diabetes: A Retrospective Cohort Study.
     J Clin Endocrinol Metab. 2024 Oct 17:dgae734. doi: 10.1210.
     PubMed     Abstract available
     
     
     
176. HUBER E, Singh T, Bunk M, Hebel M, et al
     Discrimination and precision of Continuous Glucose Monitoring in staging children with presymptomatic type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
     PubMed     Abstract available
     
     
     
177. 
     Correction to: "The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study".
     J Clin Endocrinol Metab. 2024 Oct 16:dgae708. doi: 10.1210.
     PubMed    
     
     
     
178. SULEMAN S, Madsen AL, Angquist LH, Schubert M, et al
     Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices.
     J Clin Endocrinol Metab. 2024;109:2754-2763.
     PubMed     Abstract available
     
     
     
179. KAMPMANN U, Suder LB, Nygaard M, Geiker NRW, et al
     Pre-pregnancy and gestational interventions to prevent childhood obesity.
     J Clin Endocrinol Metab. 2024 Oct 14:dgae724. doi: 10.1210.
     PubMed     Abstract available
     
     
     
180. KELLY CA, Sipos JA
     Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists.
     J Clin Endocrinol Metab. 2024 Oct 14:dgae722. doi: 10.1210.
     PubMed     Abstract available
     
     
     
181. MCINTYRE H, Kampmann U, Dalsgaard Clausen T, Laurie J, et al
     Gestational diabetes: an update sixty years after O'Sullivan and Mahan.
     J Clin Endocrinol Metab. 2024 Oct 11:dgae709. doi: 10.1210.
     PubMed     Abstract available
     
     
     
182. HSU JC, Yang YY, Chuang SL, Lin LY, et al
     Long-term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure with Preserved Ejection Fraction.
     J Clin Endocrinol Metab. 2024 Oct 9:dgae715. doi: 10.1210.
     PubMed     Abstract available
     
     
     
183. BROSSFIELD AV, McMahon DJ, Fernando J, Omeragic B, et al
     The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women with Type 2 Diabetes: a Randomized Clinical Trial.
     J Clin Endocrinol Metab. 2024 Oct 8:dgae700. doi: 10.1210.
     PubMed     Abstract available
     
     
     
184. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
     Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
     J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
     PubMed     Abstract available
     
     
     
185. KEMPEGOWDA P, Castro-Revoredo I, Umpierrez GE
     Data-Driven Cluster Analysis Reveals Distinct Diabetes Subtypes in Black/African Americans in the United States.
     J Clin Endocrinol Metab. 2024 Oct 4:dgae680. doi: 10.1210.
     PubMed    
     
     
     
186. DUFT RG, Bonfante ILP, Palma-Duran SA, Chacon-Mikahil MPT, et al
     Response to Letter to the Editor from Chen and Shan: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes".
     J Clin Endocrinol Metab. 2024 Oct 1:dgae685. doi: 10.1210.
     PubMed    
     
     
     
187. CHEN Q, Shan D
     Letter to the Editor from Chen and Shan: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes".
     J Clin Endocrinol Metab. 2024 Oct 1:dgae684. doi: 10.1210.
     PubMed    
     
     
     September 2024
188. ECHOUFFO-TCHEUGUI JB, Dagogo-Jack S
     Aldosterone and Diabetes Risk: An Association in Need of Mechanistic Insights.
     J Clin Endocrinol Metab. 2024 Sep 23:dgae662. doi: 10.1210.
     PubMed    
     
     
     
189. LEBLANC E, Brooks N, Davies M, Chatterjee R, et al
     Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and CVD: Developments and Knowledge Gaps.
     J Clin Endocrinol Metab. 2024 Sep 23:dgae655. doi: 10.1210.
     PubMed     Abstract available
     
     
     
190. WEBER DR, O'Brien KO, Ballester L, Rackovsky N, et al
     Greater urinary calcium excretion is associated with diminished bone accrual in youth with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
     PubMed     Abstract available
     
     
     
191. CHANG L, Liu Y, Gu Y, Yan S, et al
     Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2024;109:2673-2680.
     PubMed     Abstract available
     
     
     
192. DAGOGO-JACK S, Asuzu P, Wan J, Grambergs R, et al
     Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.
     J Clin Endocrinol Metab. 2024;109:2530-2540.
     PubMed     Abstract available
     
     
     
193. LEE MJ, Bae JH, Khang AR, Yi D, et al
     1-Hour Post-Load Glucose: Early Screening for High Risk of Type 2 Diabetes in Koreans with Normal Fasting Glucose.
     J Clin Endocrinol Metab. 2024 Sep 14:dgae632. doi: 10.1210.
     PubMed     Abstract available
     
     
     
194. ELAM RE, Johnson KC, Xu H, Isales CM, et al
     Predictors of fracture in middle-aged and older adults with type 2 diabetes and overweight or obesity.
     J Clin Endocrinol Metab. 2024 Sep 11:dgae623. doi: 10.1210.
     PubMed     Abstract available
     
     
     
195. SPARTANO NL, Sultana N, Lin H, Cheng H, et al
     Defining continuous glucose monitor time in range in a large community-based cohort without diabetes.
     J Clin Endocrinol Metab. 2024 Sep 11:dgae626. doi: 10.1210.
     PubMed     Abstract available
     
     
     
196. SON J, Accili D
     Dedifferentiation as a stealthy disruptor of beta-cell function in diabetes.
     J Clin Endocrinol Metab. 2024 Sep 11:dgae624. doi: 10.1210.
     PubMed    
     
     
     
197. MITRO SD, Waetjen LE, Lee C, Wise LA, et al
     Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN).
     J Clin Endocrinol Metab. 2024 Sep 11:dgae625. doi: 10.1210.
     PubMed     Abstract available
     
     
     
198. WEBB-ROBERTSON BM, Wu W, Flores JE, Bramer LM, et al
     RNA Splicing Events in Circulation Distinguish Individuals with and without New-Onset Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Sep 10:dgae622. doi: 10.1210.
     PubMed     Abstract available
     
     
     
199. PACCOU J
     Bone Microarchitecture in Older Men with Type 2 Diabetes: The Importance of Bone Size.
     J Clin Endocrinol Metab. 2024 Sep 6:dgae614. doi: 10.1210.
     PubMed    
     
     
     
200. KARAKUS KE, Fleury T, Baschal EE, McDaniel KA, et al
     Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.
     J Clin Endocrinol Metab. 2024 Sep 4:dgae608. doi: 10.1210.
     PubMed     Abstract available
     
     
     
201. BENNETT WL, He JH, Michos ED, Kalyani RR, et al
     Weight Loss Differentially Impacts Sex Hormones in Women and Men with Type 2 Diabetes: Look AHEAD Sex Hormone Study.
     J Clin Endocrinol Metab. 2024 Sep 2:dgae584. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2024
202. YANG C, Ji L, Han X
     Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease: a Meta-analysis.
     J Clin Endocrinol Metab. 2024 Aug 30:dgae602. doi: 10.1210.
     PubMed     Abstract available
     
     
     
203. MUCINSKI JM, Distefano G, Dube J, Toledo FGS, et al
     Insulin sensitivity and skeletal muscle mitochondrial respiration in Black and White women with obesity.
     J Clin Endocrinol Metab. 2024 Aug 29:dgae600. doi: 10.1210.
     PubMed     Abstract available
     
     
     
204. MENZAGHI C, Marucci A, Mastroianno M, Di Ciaccia G, et al
     Inflammation and prediction of death in type 2 diabetes. Evidence of an intertwined link with tryptophan metabolism.
     J Clin Endocrinol Metab. 2024 Aug 28:dgae593. doi: 10.1210.
     PubMed     Abstract available
     
     
     
205. KRAMER CK, Zinman B, Feig DS, Retnakaran R, et al
     The impact of time-restricted eating on beta-cell function in adults with type 2 diabetes: a randomized cross-over trial.
     J Clin Endocrinol Metab. 2024 Aug 28:dgae594. doi: 10.1210.
     PubMed     Abstract available
     
     
     
206. TOPPARI J, Veijola R
     Symptomatic type 1 diabetes is approaching, but when?
     J Clin Endocrinol Metab. 2024 Aug 22:dgae578. doi: 10.1210.
     PubMed    
     
     
     
207. ROMERES D, Ruchi FNU, Breton MD, Basu A, et al
     Post Prandial Glucose Turnover Differs Between Adolescents & Adults with Type 1 Diabetes: Triple Tracer Mixed Meal Study.
     J Clin Endocrinol Metab. 2024 Aug 22:dgae585. doi: 10.1210.
     PubMed     Abstract available
     
     
     
208. HA J, Kim JY, Springer M, Chhabra A, et al
     A Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth with Obesity.
     J Clin Endocrinol Metab. 2024 Aug 22:dgae582. doi: 10.1210.
     PubMed     Abstract available
     
     
     
209. CHENG W, Geng S, Li Y, Chen R, et al
     Sex Differences in 'Life's Essential 8' cardiovascular health and Type 2 Diabetes Mellitus Risk Across Menopause Stages.
     J Clin Endocrinol Metab. 2024 Aug 16:dgae557. doi: 10.1210.
     PubMed     Abstract available
     
     
     
210. HAO L, Xue J
     Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
     J Clin Endocrinol Metab. 2024 Aug 16:dgae554. doi: 10.1210.
     PubMed    
     
     
     
211. GIONTELLA A, Akerlund M, Bronton K, Fava C, et al
     Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus.
     J Clin Endocrinol Metab. 2024 Aug 13:dgae510. doi: 10.1210.
     PubMed     Abstract available
     
     
     
212. LAMACCHIA O, Menzaghi C, Copetti M, Mastroianno M, et al
     GFR decline predicts total mortality and mediates the effect of tryptophan metabolism on death risk in type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Aug 13:dgae551. doi: 10.1210.
     PubMed     Abstract available
     
     
     
213. WU L, Carlino MS, Brown DA, Long GV, et al
     Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
     J Clin Endocrinol Metab. 2024 Aug 13:dgae555. doi: 10.1210.
     PubMed    
     
     
     
214. ERIKSEN R, White MC, Dawed AY, Perez IG, et al
     The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study.
     J Clin Endocrinol Metab. 2024;109:e1697-e1707.
     PubMed     Abstract available
     
     
     
215. KAMIMOTO JLJ, Li Z, Gal RL, Castle JR, et al
     Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.
     J Clin Endocrinol Metab. 2024;109:2233-2241.
     PubMed     Abstract available
     
     
     
216. ARMATO J, DeFronzo RA, Abdul-Ghani M, Ruby R, et al
     Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES).
     J Clin Endocrinol Metab. 2024 Aug 7:dgae540. doi: 10.1210.
     PubMed     Abstract available
     
     
     
217. ABU IRSHEED G, Martyn-Nemeth P, Baron KG, Reutrakul S, et al
     Sleep disturbances in type 1 diabetes and mitigating cardiovascular risk.
     J Clin Endocrinol Metab. 2024 Aug 6:dgae539. doi: 10.1210.
     PubMed     Abstract available
     
     
     
218. HE X, Cao L, Fu X, Wu Y, et al
     The association between telomere length and diabetes mellitus: accumulated evidence from observational studies.
     J Clin Endocrinol Metab. 2024 Aug 1:dgae536. doi: 10.1210.
     PubMed     Abstract available
     
     
     
219. NI J, Su H, Wang Y, Lu W, et al
     Relationship between 1,5-anhydroglucitol and renal function assessed by dynamic renal scintigraphy in type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Aug 1:dgae509. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2024
220. ISMAIL HM, Perera D, Mandal R, DiMeglio LA, et al
     Gut microbial changes associated with obesity in youth with type 1 diabetes: a Pilot Study.
     J Clin Endocrinol Metab. 2024 Jul 30:dgae529. doi: 10.1210.
     PubMed     Abstract available
     
     
     
221. LU B, Li P, Crouse AB, Grimes T, et al
     Data-driven Cluster Analysis Reveals Increased Risk for Severe Insulin-Deficient Diabetes in Black/African Americans.
     J Clin Endocrinol Metab. 2024 Jul 30:dgae516. doi: 10.1210.
     PubMed     Abstract available
     
     
     
222. WANG WJ, He H, Fang F, Liu X, et al
     Cord Blood Fetuin-B, Fetal Growth Factors and Lipids in Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2024 Jul 29:dgae520. doi: 10.1210.
     PubMed     Abstract available
     
     
     
223. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
     Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial.
     J Clin Endocrinol Metab. 2024 Jul 26:dgae522. doi: 10.1210.
     PubMed     Abstract available
     
     
     
224. SHEN I, Usala RL, Mohseni M, Bouxsein ML, et al
     Adolescent girls with type 1 diabetes develop changes in bone prior to evidence of clinical neuropathy.
     J Clin Endocrinol Metab. 2024 Jul 26:dgae511. doi: 10.1210.
     PubMed     Abstract available
     
     
     
225. SONG DK, Oh J, Sung YA, Hong YS, et al
     All-cause mortality and incidence of cardiovascular diseases in lean patients with newly diagnosed type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Jul 26:dgae449. doi: 10.1210.
     PubMed     Abstract available
     
     
     
226. SASIDHARAN PILLAI S, Gagnon CA, Foster C, Ashraf AP, et al
     Exploring the Gut Microbiota: Key Insights into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Jul 23:dgae499. doi: 10.1210.
     PubMed     Abstract available
     
     
     
227. D'ADDIO F, Lazzaroni E, Lunati ME, Preziosi G, et al
     Vaccinome landscape in nearly 620,000 patients with diabetes.
     J Clin Endocrinol Metab. 2024 Jul 23:dgae476. doi: 10.1210.
     PubMed     Abstract available
     
     
     
228. JIA X, Lin H, Ding Y, Gu X, et al
     Serum Medium-Chain Fatty Acids and the Risk of Incident Diabetes: Findings from the 4C Study.
     J Clin Endocrinol Metab. 2024 Jul 20:dgae483. doi: 10.1210.
     PubMed     Abstract available
     
     
     
229. YOUSIF MF, Dolak KD, Adhikari S, White PC, et al
     Risk factors for adverse outcomes in children with diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2024 Jul 20:dgae500. doi: 10.1210.
     PubMed     Abstract available
     
     
     
230. KANG M, Zhu C, Lai M, Weng J, et al
     Machine Learning-Based Prediction of Large-for-Gestational Age Infants in Mothers with Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2024 Jul 16:dgae475. doi: 10.1210.
     PubMed     Abstract available
     
     
     
231. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
     Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
     J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
     PubMed     Abstract available
     
     
     
232. TIAN S, Guo T, Qian F, Qiu Z, et al
     Fish Oil, Plasma n-3 PUFAs, and Risk of Macro- and Microvascular Complications among Individuals with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Jul 12:dgae482. doi: 10.1210.
     PubMed     Abstract available
     
     
     
233. FARAJ M, Schwartz AV, Burghardt AJ, Black D, et al
     Risk Factors for Bone Microarchitecture Impairments in Older Men with Type 2 Diabetes - The MrOS Study.
     J Clin Endocrinol Metab. 2024 Jul 12:dgae452. doi: 10.1210.
     PubMed     Abstract available
     
     
     
234. SHAH VP, Nayfeh T, Alsawaf Y, Saadi S, et al
     A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D.
     J Clin Endocrinol Metab. 2024;109:1961-1974.
     PubMed     Abstract available
     
     
     
235. GROSSMANN M, Robledo KP, Daniel M, Handelsman DJ, et al
     Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial.
     J Clin Endocrinol Metab. 2024;109:2019-2028.
     PubMed     Abstract available
     
     
     
236. SIMS EK, Cuthbertson D, Jacobsen L, Ismail HM, et al
     Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
     J Clin Endocrinol Metab. 2024;109:2116-2123.
     PubMed     Abstract available
     
     
     
237. CORDINER RLM, Bedair K, Mari A, Pearson E, et al
     Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia.
     J Clin Endocrinol Metab. 2024;109:2106-2115.
     PubMed     Abstract available
     
     
     
238. WANG HH, Lin SH, Hung SY, Chiou YY, et al
     Renal protective effect of metformin in type 2 diabetes patients.
     J Clin Endocrinol Metab. 2024 Jul 11:dgae477. doi: 10.1210.
     PubMed     Abstract available
     
     
     
239. HENNEY AE, Gillespie CS, Lai JYM, Schofield P, et al
     Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome.
     J Clin Endocrinol Metab. 2024 Jul 11:dgae481. doi: 10.1210.
     PubMed    
     
     
     
240. ABU-NEJEM R, Hannon TS
     Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Jul 4:dgae463. doi: 10.1210.
     PubMed     Abstract available
     
     
     
241. CAMERON-PIMBLETT A, La Rosa C, Davies MC, Suntharalingham JP, et al
     Characterization of Turner Syndrome-associated diabetes mellitus.
     J Clin Endocrinol Metab. 2024 Jul 4:dgae357. doi: 10.1210.
     PubMed     Abstract available
     
     
     
242. WANG W, Xiao W, Song Z, Zhuang Z, et al
     Fetal/maternal-determined birth weight and adulthood type 2 diabetes and its subtypes: a Mendelian randomization study.
     J Clin Endocrinol Metab. 2024 Jul 4:dgae455. doi: 10.1210.
     PubMed     Abstract available
     
     
     
243. HORMAZABAL-AGUAYO I, Huerta-Uribe N, Munoz-Pardeza J, Ezzatvar Y, et al
     Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Jul 2:dgae451. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2024
244. LETH-MOLLER M, Hulman A, Kampmann U, Hede S, et al
     Effect of gestational diabetes on fetal growth rate and later overweight in the offspring.
     J Clin Endocrinol Metab. 2024 Jun 25:dgae428. doi: 10.1210.
     PubMed     Abstract available
     
     
     
245. LANKINEN MA, Nuotio P, Kauppinen S, Koivu N, et al
     Effects of genetic risk on incident type 2 diabetes and glycemia: the T2D-GENE lifestyle intervention trial.
     J Clin Endocrinol Metab. 2024 Jun 18:dgae422. doi: 10.1210.
     PubMed     Abstract available
     
     
     
246. NEDUNGADI D, Adesanya TMA, Rayan MN, Zhao S, et al
     The Association of Adiposity and RAAS with Incident Diabetes in African Americans: The Jackson Heart Study.
     J Clin Endocrinol Metab. 2024 Jun 17:dgae396. doi: 10.1210.
     PubMed     Abstract available
     
     
     
247. FRIAS JP, De Block C, Brown K, Wang H, et al
     Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).
     J Clin Endocrinol Metab. 2024;109:1745-1753.
     PubMed     Abstract available
     
     
     
248. DI FILIPPO L, Giustina A
     Vitamin D deficiency and type 2 diabetes: the dangerous link between two modern pandemics.
     J Clin Endocrinol Metab. 2024 Jun 13:dgae390. doi: 10.1210.
     PubMed    
     
     
     
249. CALVIGIONI M, Biancalana E, Mazzantini D, Celandroni F, et al
     In-depth microbiological characterization of urine from subjects with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Jun 13:dgae389. doi: 10.1210.
     PubMed     Abstract available
     
     
     
250. KJAERGAARD AD, Ellervik C, Jessen N, Lessard SJ, et al
     Cardiorespiratory fitness, body composition, diabetes, and longevity: a two-sample Mendelian randomization study.
     J Clin Endocrinol Metab. 2024 Jun 12:dgae393. doi: 10.1210.
     PubMed     Abstract available
     
     
     
251. VITALE RJ, Tinsley LJ, Volkening LK, Laffel LM, et al
     Lower Independent Self-Care Readiness Persists over Time in Teens with Type 1 Diabetes and Executive Function Challenges.
     J Clin Endocrinol Metab. 2024 Jun 12:dgae391. doi: 10.1210.
     PubMed     Abstract available
     
     
     
252. LIU S, Tham WK, Lee J, Ang K, et al
     Plasma ceramides predict all-cause and cause-specific mortality in individuals with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Jun 8:dgae388. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2024
253. MONTASER E, Farhy LS, Kovatchev BP
     Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics.
     J Clin Endocrinol Metab. 2024 May 31:dgae379. doi: 10.1210.
     PubMed     Abstract available
     
     
     
254. 
     Correction to: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals With Obesity and Type 2 Diabetes".
     J Clin Endocrinol Metab. 2024 May 31:dgae328. doi: 10.1210.
     PubMed    
     
     
     
255. REDLING D, Bialak S, El Ghormli L, Chernausek SD, et al
     Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-Onset Type 2 Diabetes: The TODAY study.
     J Clin Endocrinol Metab. 2024 May 30:dgae376. doi: 10.1210.
     PubMed     Abstract available
     
     
     
256. XIE C, Huang W, Rayner CK, Horowitz M, et al
     Letter to the Editor From Xie et al: "The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes".
     J Clin Endocrinol Metab. 2024 May 27:dgae366. doi: 10.1210.
     PubMed    
     
     
     
257. 
     Correction to: "Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses".
     J Clin Endocrinol Metab. 2024 May 23:dgae343. doi: 10.1210.
     PubMed    
     
     
     
258. TRIOLO TM, Parikh HM, Tosur M, Ferrat L, et al
     Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives.
     J Clin Endocrinol Metab. 2024 May 20:dgae349. doi: 10.1210.
     PubMed     Abstract available
     
     
     
259. POKHAREL P, Blekkenhorst LC, Bondonno CP, Murray K, et al
     Associations of vegetable and potato intakes with markers of type 2 diabetes risk in the AusDiab cohort.
     J Clin Endocrinol Metab. 2024 May 15:dgae333. doi: 10.1210.
     PubMed     Abstract available
     
     
     
260. LIU J, Ai C, Li Z, Huang X, et al
     Titration of sedentary behavior with varying physical activity levels reduces mortality in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 May 13:dgae323. doi: 10.1210.
     PubMed     Abstract available
     
     
     
261. 
     Correction to: "Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study".
     J Clin Endocrinol Metab. 2024 May 13:dgae321. doi: 10.1210.
     PubMed    
     
     
     
262. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
     Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
     PubMed     Abstract available
     
     
     
263. DENG R, Chen W, Zhang Z, Zhang J, et al
     Association between visceral obesity index and diabetes: a systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2024 May 6:dgae303. doi: 10.1210.
     PubMed     Abstract available
     
     
     
264. NICOLI CD, Long DL, Plante TB, Judd SE, et al
     N-Terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
     J Clin Endocrinol Metab. 2024 May 4:dgae301. doi: 10.1210.
     PubMed     Abstract available
     
     
     
265. OKOSHI C, Kyozuka H, Fukuda T, Yasuda S, et al
     Risk of gestational diabetes in women with PCOS based on body mass index: The Japan Environment and Children's Study.
     J Clin Endocrinol Metab. 2024 May 4:dgae293. doi: 10.1210.
     PubMed     Abstract available
     
     
     
266. SCAIRATI R, Auriemma RS, Di Meglio S, Del Vecchio G, et al
     Risk Assessment of Diabetes Mellitus during and after Pregnancy in Women with Prolactinomas.
     J Clin Endocrinol Metab. 2024 May 2:dgae289. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2024
267. LING P, Yang D, Wang C, Zheng X, et al
     Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
     PubMed     Abstract available
     
     
     
268. KAARNIRANTA K, Valtanen M, Keinanen-Kiukaanniemi S, Tuomilehto J, et al
     Long-term cumulative incidence of clinically diagnosed retinopathy in the Finnish Diabetes Prevention Study.
     J Clin Endocrinol Metab. 2024 Apr 25:dgae287. doi: 10.1210.
     PubMed     Abstract available
     
     
     
269. HSU HY, Chern YJ, Hsu MS, Yeh TL, et al
     Colorectal Cancer and Subsequent Diabetes Risk: A Population-based Cohort Study in Taiwan.
     J Clin Endocrinol Metab. 2024 Apr 25:dgae257. doi: 10.1210.
     PubMed     Abstract available
     
     
     
270. HAGELQVIST PG, Andersen A, Maytham K, Andreasen CR, et al
     Hemostatic Effects of Exercise-Related Hypoglycemia in Male Persons With Type 1 Diabetes.
     J Clin Endocrinol Metab. 2024 Apr 20:dgae278. doi: 10.1210.
     PubMed     Abstract available
     
     
     
271. NERILD HH, Gilliam-Vigh H, Ellegaard AM, Forman JL, et al
     Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls.
     J Clin Endocrinol Metab. 2024 Apr 18:dgae261. doi: 10.1210.
     PubMed     Abstract available
     
     
     
272. 
     Correction to: "Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics".
     J Clin Endocrinol Metab. 2024 Apr 17:dgae232. doi: 10.1210.
     PubMed    
     
     
     
273. GURUNG RL, Zheng H, Koh HWL, Yiamunaa M, et al
     Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Apr 16:dgae266. doi: 10.1210.
     PubMed     Abstract available
     
     
     
274. CHE J, He N, Kuang X, Zheng C, et al
     Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
     J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
     PubMed     Abstract available
     
     
     
275. LIANG Q, Li M, Huang G, Li R, et al
     Genetic Susceptibility, Mendelian randomization and Nomogram Model Construction of Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2024 Apr 16:dgae200. doi: 10.1210.
     PubMed     Abstract available
     
     
     
276. DU X, Zhu Y, Lu W, Fu N, et al
     Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
     J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
     PubMed     Abstract available
     
     
     
277. ZU P, Wang H, Zhang L, Bian H, et al
     Insulinemic and inflammatory dietary patterns show enhanced predictive potential for gestational diabetes mellitus risk.
     J Clin Endocrinol Metab. 2024 Apr 13:dgae238. doi: 10.1210.
     PubMed     Abstract available
     
     
     
278. LIN X, Zhu K, Qiu Z, Li R, et al
     Associations Between Beverage Consumption and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Apr 12:dgae242. doi: 10.1210.
     PubMed     Abstract available
     
     
     
279. LI L, Ji W, Wang Z, Cheng Y, et al
     Air pollution and diabetes mellitus: Association and validation in a desert area in China.
     J Clin Endocrinol Metab. 2024 Apr 9:dgae219. doi: 10.1210.
     PubMed     Abstract available
     
     
     
280. PIEMONTE E, Bruzzaniti S, Galgani M
     Type 2 Diabetes: Fighting Inflammation Fire of T lymphocytes with Magnesium.
     J Clin Endocrinol Metab. 2024 Apr 9:dgae231. doi: 10.1210.
     PubMed    
     
     
     
281. MOON S, Lee M, Lee JS, Lee J, et al
     Association between hypotension during pancreatectomy and development of postoperative diabetes.
     J Clin Endocrinol Metab. 2024 Apr 9:dgae227. doi: 10.1210.
     PubMed     Abstract available
     
     
     
282. FU Y, Lu M, Zhang K, Sun Y, et al
     Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: A prospective cohort study.
     J Clin Endocrinol Metab. 2024 Apr 4:dgae221. doi: 10.1210.
     PubMed     Abstract available
     
     
     
283. WEN H, Niu X, Yu R, Zhao R, et al
     Association of Serum AGR With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes.
     J Clin Endocrinol Metab. 2024 Apr 4:dgae215. doi: 10.1210.
     PubMed     Abstract available
     
     
     
284. PUDDU PE, Menotti A
     Diabetes duration and the reverse impact between cholesterol levels and risk among individuals with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Apr 3:dgae217. doi: 10.1210.
     PubMed    
     
     
     March 2024
285. SAEI GHARE NAZ M, Farhadi-Azar M, Noroozzadeh M, Farahmand M, et al
     Follicle-Stimulating Hormone and Diabetes in Postmenopausal Women: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2024 Mar 30:dgae198. doi: 10.1210.
     PubMed     Abstract available
     
     
     
286. SCHOWE AM, Czamara D, Lahti-Pulkkinen M, Girchenko P, et al
     Serial Diurnal Salivary Cortisol Profiles in 667 pregnant women - Association with Cardiometabolic Complications.
     J Clin Endocrinol Metab. 2024 Mar 29:dgae202. doi: 10.1210.
     PubMed     Abstract available
     
     
     
287. LIU JJ, Liu S, Zheng H, Lee J, et al
     Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Mar 28:dgae199. doi: 10.1210.
     PubMed     Abstract available
     
     
     
288. QIU Z, Lee DH, Lu Q, Li R, et al
     Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
     PubMed     Abstract available
     
     
     
289. 
     Correction to: "Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication".
     J Clin Endocrinol Metab. 2024 Mar 20:dgae160. doi: 10.1210.
     PubMed    
     
     
     
290. CIARDULLO S, Morabito G, Rea F, Savare L, et al
     Time trends in liver-related mortality in people with and without diabetes: Results from a population based study.
     J Clin Endocrinol Metab. 2024 Mar 20:dgae182. doi: 10.1210.
     PubMed     Abstract available
     
     
     
291. KITAMURA T
     Useful biomarkers and clinical characteristics of post-pancreatitis diabetes mellitus (PPDM).
     J Clin Endocrinol Metab. 2024 Mar 19:dgae174. doi: 10.1210.
     PubMed    
     
     
     
292. DUFT RG, Bonfante ILP, Palma-Duran SA, Chacon-Mikahil MPT, et al
     Moderate-Intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes.
     J Clin Endocrinol Metab. 2024 Mar 15:dgae177. doi: 10.1210.
     PubMed     Abstract available
     
     
     
293. MERTENS J, Roosens L, Braspenning R, Vandebeeck J, et al
     The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Mar 15:dgae175. doi: 10.1210.
     PubMed     Abstract available
     
     
     
294. FRITSCHE L, Loffler D, Kantartzis K, Flehmig G, et al
     Impact of breastfeeding duration on coagulation in women with and without history of gestational diabetes mellitus.
     J Clin Endocrinol Metab. 2024 Mar 15:dgae172. doi: 10.1210.
     PubMed     Abstract available
     
     
     
295. SUPPLI MP, Hogedal A, Bagger JI, Chabanova E, et al
     Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
     J Clin Endocrinol Metab. 2024;109:955-967.
     PubMed     Abstract available
     
     
     
296. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
     Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
     J Clin Endocrinol Metab. 2024;109:1071-1079.
     PubMed     Abstract available
     
     
     
297. 
     Correction to: "Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement".
     J Clin Endocrinol Metab. 2024 Mar 14:dgae144. doi: 10.1210.
     PubMed    
     
     
     
298. WONG AYW, Hooi NMF, Yeo BSY, Sultana R, et al
     Improving Diabetic Wound Healing Outcomes with Topical Growth Factor Therapies: Systematic Review and Network Meta-analysis of Randomised-controlled Trials.
     J Clin Endocrinol Metab. 2024 Mar 13:dgae128. doi: 10.1210.
     PubMed     Abstract available
     
     
     
299. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
     Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
     J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
     PubMed     Abstract available
     
     
     
300. CHAN YH, Chao TF, Chen SW, Lee HF, et al
     SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation.
     J Clin Endocrinol Metab. 2024 Mar 11:dgae157. doi: 10.1210.
     PubMed     Abstract available
     
     
     
301. LIU W, Cai D, Zhang R, Zhang X, et al
     A randomized clinical trial for meal bolus decision using learning-based control in adults with type 2 diabetes.
     J Clin Endocrinol Metab. 2024 Mar 7:dgae143. doi: 10.1210.
     PubMed     Abstract available
     
     
     
302. ALHENC-GELAS F, Marre M
     Young onset type2 diabetes: when gluconeogenesis is overfueled and out of control.
     J Clin Endocrinol Metab. 2024 Mar 5:dgae123. doi: 10.1210.
     PubMed    
     
     
     
303. BOURGONJE AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, et al
     Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study.
     J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210.
     PubMed     Abstract available
     
     
     
304. NIELSEN H, Windolf-Nielsen A, Scheuer SH, Damm P, et al
     Type 2 diabetes risk after gestational diabetes according to country/region of origin. A nationwide register-based study.
     J Clin Endocrinol Metab. 2024 Mar 1:dgae113. doi: 10.1210.
     PubMed     Abstract available
     
     
     February 2024
305. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
     Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
     J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
     PubMed     Abstract available
     
     
     
306. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
     Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
     J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
     PubMed     Abstract available
     
     
     
307. CAI Y, Wei Q, Wang S, Lu X, et al
     All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light Chain Levels in U.S. General Adults.
     J Clin Endocrinol Metab. 2024 Feb 27:dgae102. doi: 10.1210.
     PubMed     Abstract available
     
     
     
308. DRENTHEN LCA, Ajie M, de Baaij JHF, Tack CJ, et al
     Magnesium supplementation modulates T-cell function in people with type 2 diabetes and low serum magnesium levels.
     J Clin Endocrinol Metab. 2024 Feb 27:dgae097. doi: 10.1210.
     PubMed     Abstract available
     
     
     
309. RAPINI N, Delvecchio M, Mucciolo M, Ruta R, et al
     The changing landscape of neonatal diabetes mellitus in Italy between 2003-2022.
     J Clin Endocrinol Metab. 2024 Feb 26:dgae095. doi: 10.1210.
     PubMed     Abstract available
     
     
     
310. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
     More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
     J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
     PubMed     Abstract available
     
     
     December 2023
311. RAZO-AZAMAR M, Nambo-Venegas R, Quevedo IR, Juarez-Luna G, et al
     Early pregnancy serum maternal and placenta-derived exosomes miRNAs vary based on pancreatic beta-cell function in GDM.
     J Clin Endocrinol Metab. 2023 Dec 21:dgad751. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2023
312. STAMOU MI, Smith KT, Kim H, Balasubramanian R, et al
     Polycystic Ovarian Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
     J Clin Endocrinol Metab. 2023 Nov 15:dgad664. doi: 10.1210.
     PubMed     Abstract available
     
     
     
313. ROCHA T, Melson E, Zamora J, Fernandez-Felix BM, et al
     Sex-Specific Obesity and Cardiometabolic Disease Risks in Low- and Middle-Income Countries: A Meta-Analysis Involving 3 916 276 Individuals.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad599. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2023
314. HIRSCHBERG AL
     Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
     J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
     PubMed     Abstract available
     
     
     September 2023
315. ANAWALT BD
     TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
     J Clin Endocrinol Metab. 2023 Sep 21:dgad555. doi: 10.1210.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.